Arlington, Virginia-based Surescripts announced that it has acquired ActiveRADAR, a clinical intelligence company that identifies therapeutic alternatives for prescriptions.
ActiveRADAR, formerly known as RxTE Health, is a healthcare analytics company delivering value-based reimbursement products and services for prescription drug benefits. ActiveRADAR’s clinical catalogue covers more than 165 therapeutic categories, including more than 30 specialty drug categories and more than 33,000 drug pairs.
Surescripts is an American information technology company that supports e-prescription, the electronic transmission of prescriptions between healthcare organizations and pharmacies, as well as general health information exchange of medical records. In 2022, Surescripts processed 2.34 billion electronic prescriptions filled by pharmacies nationwide.
The ActiveRADAR team will be joining Surescripts, providing faster access to insights and optimizing the value delivered by ActiveRADAR’s data. With access to ActiveRADAR’s catalog of therapeutic alternatives data, Surescripts can reduce drug spending and help provide more alternatives when deploying prescription pricing information to providers. Financial terms of the deal were not disclosed.
According to data captured from the LevinPro HC database, this transaction marks the 241st eHealth acquisition of 2023, and the 29th in the analytics specialty. This is a decrease from last year when 301 eHealth transactions, and 53 in the analytics specialty, were announced between January 1, 2022, and November 6, 2022.
